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Abstract
Bone has a complex hierarchical structure that has evolved to serve structural and metabolic roles
in the body. Due to the complexity of bone structure and the number of diseases which affect the
ultrastructural constituents of bone, it is important to develop quantitative methods to assess bone
nanoscale properties. Autosomal dominant Osteogenesis Imperfecta results predominantly from
glycine substitutions (80%) and splice site mutations (20%) in the genes encoding the α1 or α2
chains of Type I collagen. Genotype-phenotype correlations using over 830 collagen mutations
have revealed that lethal mutations are located in regions crucial for collagen-ligand binding in the
matrix. However, few of these correlations have been extended to collagen structure in bone. Here,
an atomic force microscopy-based approach was used to image and quantitatively analyze the D-
periodic spacing of Type I collagen fibrils in femora from heterozygous (Brtl/+) mice
(α1(I)G349C), compared to wild type (WT) littermates. This disease system has a well-defined
change in the col1α1 allele, leading to a well characterized alteration in collagen protein structure,
which are directly related to altered Type I collagen nanoscale morphology, as measured by the D-
periodic spacing. In Brtl/+ bone, the D-periodic spacing shows significantly greater variability on
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average and along the length of the bone compared to WT, although the average spacing was
unchanged. Brtl/+ bone also had a significant difference in the population distribution of collagen
D-period spacings. These changes may be due to the mutant collagen structure, or to the
heterogeneity of collagen monomers in the Brtl/+ matrix. These observations at the nanoscale
level provide insight into the structural basis for changes present in bone composition, geometry
and mechanical integrity in Brtl/+ bones. Further studies are necessary to link these morphological
observations to nanoscale mechanical integrity.
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Introduction
Bone is an elegant biomaterial with a complex hierarchical organization that has evolved to
serve a number of structural and metabolic functions. Bone is a two-phase composite
composed of a ductile organic matrix (~90% Type I collagen) which is reinforced by a
carbonated apatite mineral phase. Many would argue that the mechanical properties of these
constituent components of bone largely control the mechanical properties of the bone itself.
[1] Despite the importance of skeletal health to overall health, it is still not clear how the
nanoscale properties of collagen and mineral in bone, and their intimate interaction with one
another, translate into the mechanical integrity of the structure that develops at higher levels
of the bone hierarchy. [2,3] Further, it is not fully understood how alterations to the
individual constituents can change the mechanical competence of the bone. One recent study
elegantly illustrated how changes to even ancillary components of the bone matrix can
drastically alter properties across the bone hierarchy. [4] It is therefore important for
researchers to develop new quantitative methods to assess the nanoscale properties of
normal bone and to study how these properties change in response to disease.[5]
Type I collagen forms the template upon which all bones are built. Collagen is initially
synthesized as a polypeptide chain of amino acids (Figure 1) with an uninterrupted region of
repeating Gly-X-Y triplets (X and Y are often proline and hydroxyproline, respectively).[6]
Glycine has the smallest amino acid side chain (a single hydrogen atom). The significance of
glycine being present as every third amino acid is that this small side chain can be
accommodated within the central axis of a left-handed helical structure (the α helix). Other
amino acids with larger, bulkier side chains would prevent proper folding of the helix. Three
of these helical chains come together to form a right-handed triple helix. Once secreted from
the cell, non-helical propeptide ends are enzymatically cleaved, leaving a tropocollagen
molecule. Tropcollagen molecules self-assemble in a staggered, parallel manner to form a
3D fibril. Because of the space between the ends of the tropocollagen molecules and the
offset from row to row, regions of gaps and overlaps exist within the fibril and produce an
oscillating surface topography with a characteristic axial repeat pattern called the D-
periodicity.
Type I collagen is a heterotrimeric molecule composed of two α1 chains and one α2 chain.
Mutations in the genes encoding the α chains can cause diseases of bone and other tissues
such as Osteogenesis Imperfecta (OI), or brittle bone disease, and some forms of Ehlers-
Danlos Syndrome. Human OI results primarily from point mutations that cause the
substitution of a glycine residue in the triple helical region (80%) or splice site mutations
(20%) in the genes encoding the α1 or α2 chains of Type I collagen. [7,8] The disease
displays a wide spectrum of clinical severities, with more severe forms arising from changes
in the primary amino acid sequence. These changes in alpha chain structure result in delayed
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protein folding and over-modification of the collagen triple helix, and decrease collagen
quality [9], although disease severity does not correlate with the extent of collagen over-
modification. Milder forms of dominant OI arise from null mutations in one Type I collagen
allele, resulting in an underproduction of normal collagen. Depending on the severity of the
disease, symptoms range from susceptibility to fracture from mild trauma to perinatal
lethality.
Correlations between genotype and phenotype in OI utilizing over 800 mutations revealed
that mutations in the Major Ligand Binding Regions in the α1 chain and the proteoglycan
binding regions in the α2 chain were almost entirely lethal. [8] Histomorphometry of OI
bone has shown that surface-based remodelling parameters are increased in all forms of OI
but that mineralization defects are not present [10] (with the possible exception of Type VI
OI [9]). Some studies have investigated the impact of OI mutations on the structure and
mechanical integrity of non-mineralized tendon [11,12] or on the properties of the mineral in
OI bone [13], but correlations between genotype and collagen structure in OI bone are
limited. [14,15] The Brittle (Brtl) mouse, a model of human Type IV OI which has a
classical glycine substitution (a cysteine is substituted for a glycine at the 349 position of the
triple helix, Figure 1) in one col1α1 allele, was created to study how specific changes in the
amino acid sequence of collagen can lead to OI phenotypic characteristics.[16]
The need for quantitative analytical methods to assess the nanoscale morphology of collagen
in bone without tissue disruption has prompted us to study the collagen ultrastructure of
bone using atomic force microscopy (AFM). [17,18] In comparison to other high-resolution
methods used to assess the nanoscale properties of bone and other mineralized tissues,
[19,20] AFM is less destructive and requires less sample preparation, [21] implying that
measured properties are less likely artifacts of sample processing or imaging. It was
previously shown that normal Type I collagen-based tissues, including bone, contain a
distribution of Type I collagen fibril morphologies, as measured by the fibril D-periodic
spacing.[17,18] We further demonstrated that estrogen-depletion in sheep leads to a
significant change in this distribution in bone.[17] However, because the effects of estrogen
and estrogen depletion on collagen structure are not well understood, it was not possible to
ascribe a mechanism to these changes in collagen morphology. The current study was
undertaken in an attempt to study ultrastructural changes in collagen fibril structure
following a defined genetic insult. AFM was used to image and quantitatively analyze the
D-periodic spacing of Type I collagen fibrils in intact and mineralized bones from wild type
(WT) and heterozygous (Brtl/+) mice. This disease system has a well-defined change in the
col1α1 allele and in collagen protein structure. It was hypothesized that changes in the mean
D-periodic spacing as well as alterations in the D-period population distribution, might also
be present in diseased fibrils from Brtl/+ mice in comparison to their WT littermates.
Although the average D-periodic spacing was not significantly different in Brtl/+ versus WT
bone, the D-periodic spacing in Brtl/+ bone had greater variability overall and along the
length of the bone. A significant difference in the population distributions of collagen D-
periodic spacing was also present in Brtl/+ bone. These nanoscale observations provide
insight into the structural basis for changes present in bone composition, geometry and
mechanical integrity in Brtl/+ bones.
Materials and Methods
Animals
Brtl/+ and WT mice from the mixed Sv129/CD-1/C57BL/6S background strain were used
with prior approval of the NICHD Animal Care Committee (protocol # ASP 09-023) and
were sacrificed by lethal injection. Femurs from two month-old male wild type (WT, n=4)
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and Brtl/+ (n=4) mice were harvested and stripped of soft tissue before processing for
imaging.
Atomic Force Microscopy (AFM) imaging and analysis
Before use, the proximal (above the third trochanter) and distal ends of each right femur
were removed using a low-speed sectioning saw (Figure 2). The marrow cavity of each bone
was cleaned using a small tube brush. Bones were mounted, anterior-side up, to a steel disk
using a thin layer of cyanoacrylate glue. A flat polished surface of intracortical bone was
created using a 3 μm polycrystalline water-based diamond suspension and a 0.05 μm
deagglomerated alumina suspension (Buehler LTD; Lake Bluff, Il). The bones were
sonicated for 15 seconds to remove polishing residue and debris. To remove extrafibrillar
surface mineral and expose underlying collagen fibrils, the surface of each bone was
demineralized using 0.5M EDTA at a pH of 8.0 for 15 minutes, then vigorously rinsed with
ultrapure water and soaked at 4°C for at least 16 hours. EDTA is often used in mineralized
tissue research to remove mineral while keeping collagen and cells intact and viable. [22,23]
Before imaging, each sample was briefly sonicated to remove any mineral that was still
bound to the surface.
Samples were imaged in air using a PicoPlus 5500 AFM (Agilent). Images were acquired in
tapping mode using silicon cantilevers (VistaProbes T300R, tip radius < 10 nm, force
constant 40 N/m, resonance frequency 300 kHz; nanoScience Instruments; Phoenix, AZ) at
line scan rates of 2 Hz or lower at 512 lines per frame.
Making absolute x-y distance measurements with AFM has multiple limitations. Prior to
sampling, calibration of the system was performed according manufacturer guidelines. A
calibration grating with a 10 μm period was imaged with the scan size set just under the
range of the piezo (80 μm scan size) at 512 pixels by 512 pixels. This results in a pixel size
of roughly 160 nm. To overcome limitations imposed by pixel size, multiple consecutive
periods were measured. The measured period was defined as the total measured length
divided by the number of periods. The calibration was adjusted until the measured period
was within 25 nm of the actual 10 μm period. This calibration method results in a maximum
error of 0.25%, which is less than the 1% tolerance specified by the manufacturer. For the
imaging of collagen fibrils, scan sizes were reduced to 3.5 μm at 512 × 512 pixels. Because
of the effective linearity of the piezo, error scales with the reduction of scan size, reducing
the 25 nm tolerance to 1.1 nm.
Image Analysis
Images were acquired from 9 axial locations in each bone sample (designated 1–9 beginning
at the proximal end of the sample, Figure 2). At each location, 70 μm × 70 μm scans were
performed to find sites for closer inspection, then the scan size was decreased to a final size
of 3.5 μm × 3.5 μm. Amplitude images were analyzed to investigate the D-periodic spacing,
chosen as our key metric of fibril morphology (Figure 1). Five to ten fibrils from each axial
location were analyzed (SPIP v5.0.6, Image Metrology; Hørsholm, Denmark). Following
image capture, a rectangular region of interest (ROI) was chosen along straight segments of
individual fibrils (Figure 3). The ROI was drawn to ensure that it started and ended at the
edge of a gap zone, a method which minimizes edge effects that can degrade resolution. For
each evaluated fibril, a two dimensional Fast Fourier Transform (2D FFT) was performed
and the primary peak from the 2D power spectrum was analyzed to determine the value of
the D-periodic spacing for that fibril. This process decouples the measured D-Period repeat
distance from both pixel size and fibril orientation. A detailed analysis of the uncertainty
associated with this type of measurement sets the minimum bin size for population studies at
0.8 nm. For all histograms, the bin size was therefore set at 1 nm.
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All statistical analyses utilized SPSS (Version 16.0, SPSS Inc.). For all investigations, a
value of p<0.05 was considered significant. To investigate differences in fibril morphology
as a function of genotype, D-periodic spacing values measured from an individual bone
sample were averaged, yielding an single value for that sample. The values from WT (n=4)
and Brtl/+ (n=4) mice were then compared using One Way ANOVA.
To examine differences in the distribution of fibril morphology between genotypes,
histograms and the Cumulative Distribution Function (CDF) of each group were computed.
The CDF shows the fraction of a given sample which is contained up to a particular value,
easily demonstrating differences between distributions in both mean and standard deviation.
To test for statistically significant differences between distributions, Kolmogorov-Smirnov
(K-S) tests were applied to the data. This test is sensitive to changes in both the mean value
and standard deviation of a distribution.
Results
The D-periodic spacing was chosen as the key metric of fibril morphology (Figure 1). This
measure captures aspects of fibril structure which may be related to the state of the
individual molecular triple helices, post-translational modifications and cross-linking. To
quantitatively assess the D-periodic spacing in murine cortical bone as a function of OI
genotype, femora from 2 month old male mice were used. In the intracortical bone along the
anterior surface of the diaphysis, 9 locations were analyzed in each sample. Five to ten
fibrils were analyzed at each axial location. Within each genotype, measurements at each
axial location were pooled to assess the variability in morphology along the length of the
femur (Figure 4). The spread of the data at each axial location is qualitatively larger in the
Brtl/+ bones (B) in comparison to the WT (A) bones.
All measurements within each bone were averaged to yield the mean fibril spacing for that
bone, then the 4 WT values were compared with the 4 Brtl/+ values (Figure 5). Within each
genotype, the overall mean values were 67.6 nm and 67.4 nm for WT and Brtl/+,
respectively. There was no significant effect of genotype on mean fibril spacing (p=0.392)
when the mean values from the 4 bones in each genotype were compared by One Way
ANOVA.
In addition to mean differences in morphology, important information can also be obtained
by viewing the population distribution of fibril morphologies within each genotype (Figure
6). Figure 6A shows that a distribution of spacings exists in each genotype and that these
distributions differ between WT and dysplastic bone. The main population of fibrils in each
group was defined using the mean of the WT group ± 1 standard deviation, which is 66 - 70
nm (Figure 6A). Within this range, 75% of WT, but only 55% of Brtl/+ fibrils, were found.
As a second method to visualize these distributions, the Cumulative Distribution Function
(CDF) was computed from the measurements in each group (Figure 6B). Both the histogram
and the CDF indicate that the Brtl/+ bones have populations of fibrils with both closer and
longer spacings than does the WT group. To test for statistically significant differences
between distributions, a fundamentally different comparison than the difference in means
tested above using One Way ANOVA, Kolmogorov-Smirnov (K-S) tests were applied to the
data. This test is sensitive to changes in both the mean value and standard deviation of a
distribution. The population distribution of the D-periodic spacings in Brtl/+ bones was
significantly different than the WT bones (p=0.001).
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In this study, surface characterization of Type I collagen at the nanoscale was linked with
biology in an effort to understand the ultrastructural mechanisms of an Osteogenesis
Imperfecta (OI) phenotype in bone. Normal bone contains a distribution of Type I collagen
fibril morphologies, as measured by the fibril D-periodic spacing. [17,18] A previous study
in sheep subjected to two years of ovariectomy-induced estrogen depletion demonstrated a
quantifiable change in this distribution as a function of the disease state. [17] However, the
direct effects of estrogen-depletion on collagen are unknown and it is therefore difficult to
understand why this change in the distribution of fibril morphologies exists. A major
strength of the current study is that a disease system with a well-defined genetic change in
the col1α1 allele [16] and well characterized alterations in collagen protein structure [24–26]
was directly related to alterations in Type I collagen nanoscale morphology. By
characterizing the mean fibril D-spacing and the distribution of fibril morphologies in the
bone of normal mice and mice that were heterozygous for a specific col1a1 point mutation
(G349C), phenotypic changes in the collagen fibril ultrastructure were detected. Studies are
currently underway to begin linking these differences in ultrastructural morphology to
alterations in the nanoscale mechanical behaviour of Type I collagen.
Although the mean D-periodic spacing of Type I collagen fibrils in Brtl/+ bone was not
significantly different than in WT, the distribution of spacing values was distinctive between
the genotypes (Figure 6). Further, there was more variation in fibril morphology along the
axial length of Brtl/+ bones (Figure 4). In light of what is known about the mutation in Brtl/
+ mice [16] and its detrimental effects on collagen synthesis, [24,26,27] bone structure and
overall bone mechanical integrity, [27] these findings at the nanoscale are important. Bones
from Brtl/+ mice have normal levels of col1a1 and col1a2 transcripts, [25] and produce
Type I collagen molecules with 3 different chain compositions (2 normal α1 chains, +/+; 1
normal and 1 mutant α1 chain, G349C/+; 2 mutant α1 chains, G349C/G349C) in an
expected 1:2:1 ratio. Abnormal trafficking of collagen molecules with a single mutant chain
leads to the accumulation of collagen in the endoplasmic reticulum resulting in delayed
secretion, over modification and selective degradation [26]. As a result, among the total
collagen molecules secreted from Brtl/+ cells, the proportion with a single mutant chain
ranges from 26–40%, considerably lower than the theoretical 50%. [26] Once mutant
molecules are secreted from cells, they are efficiently incorporated into collagen fibrils and
form crosslinks with the same efficiency as in WT mice. [24,26]
Fibrils formed in Brtl/+ mice are thinner and exhibit a disruption of the normal quasi-
crystalline lateral packing, but the methods used to measure these properties were indirect.
[24] Data from the current study directly demonstrate that the incorporation of mutant
molecules changes the intrafibrillar organization of collagen fibrils. Changes in the D-period
spacing are likely driven by alterations in the end-to end spacing of collagen molecules
within the fibril due to changes in intracellular tropocollagen processing and assembly, by a
change in the tightness of the twist of the fibril, or even by differences in mineralization
within the fibrils themselves. [28–30] Since collagen forms the template for mineralization,
altered collagen may also account for changes in mineral composition and density [27,31]
and may result in differences in the relationship between collagen and mineral. It is also
possible that changes in the relationship between collagen, non-collagenous proteins and
mineral are partially responsible for the observed changes in fibril morphology.
Recent modeling studies have investigated the effects of point mutations on collagen
structure [32] and mechanical integrity. [33,34] Normal collagen helices and helices with
single amino acid point mutations were modelled and the incorporation of these helices into
triple helical tropocollagen molecules was investigated. The major conclusion from these
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studies was that the alteration of the normal amino acid sequence leads to packing
differences in collagen molecules which could contribute to the compromised mechanical
integrity associated with OI. Specifically, at the single molecule level, OI mutations led to
weakened intermolecular adhesion, increased intermolecular lateral spacing and, ultimately,
decreased mechanical stiffness of individual tropocollagen molecules. Changes in these
parameters scaled with the severity of the mutation. In addition, failure strength and yield
strain were detrimentally impacted in collagen fibrils with the most severe mutations. A
limitation of this fibrillar-level study is that a mesoscale model was used and the output of
the nanomechanical investigation served only as an input parameter in the formulation of the
model. Therefore, this model assumes that all tropocollagen molecules within the tested
fibril are the same. As mentioned above, the heterozygous Brtl/+ model has three different
chain compositions which are then randomly incorporated into fibrils, complicating the
comparison to the current study. Here, changes in fibril D-periodicity caused by the
alteration in amino acid sequence from a single point mutation in OI are directly observed,
although this is a different measure of fibril spacing than the one mentioned in the modeling
studies. Regardless, the theoretical results predict a wider range of intermolecular spacings,
which may relate to the broader distribution of D-periodic spacing directly observed here.
In the current study, mutant bone had large percentages of fibrils with spacing that were
either larger or smaller than the main population of the WT fibrils (defined as the mean ± 1
standard deviation). It is postulated that the large population of fibrils with spacings less
than the mean minus 1 standard deviation of WT values observed here (~25% of all mutant
fibrils) means that less space is available inside of these fibrils for water and mineral to
occupy. The decrease in water will have a direct negative impact on the viscoelastic and
post-yield behaviour of the fibril. Less space within these fibrils may also limit the ability of
mineral to nucleate and grow within the confines of the fibrillar template.[15] If true, an
increased proportion of extrafibrillar mineral could lead to the known hypermineralization
phenotype that is characteristic of Brtl/+ mice.[27] Another possibility is that the population
of fibrils with spacings greater that the main WT population (~15% of all mutant fibrils)
have more space within the fibril which may allow mineral crystals to grow larger (also
manifesting as increased mineralization) and become more brittle. The link between these
alterations in fibril morphology and direct changes in the mechanical integrity of those
fibrils requires further investigation.
Conclusion
In conclusion, the nanoscale morphology of Type I collagen, as measured by the fibril D-
periodic spacing, was probed to gain a mechanistic understanding of changes induced in the
collagen ultrastructure of bone in a murine model of Type IV Osteogenesis Imperfecta.
Although the average D-periodic spacing in Brtl/+ bone was the same as WT, Brtl/+ bone
shows greater variability of D-periodic spacing along the length of the bone and a significant
difference in the population distribution of collagen fibrils. These observations at the
nanoscale level provide insight into the structural basis for changes in bone composition,
geometry and mechanical integrity in Brtl/+ bones. These changes in morphology may be
directly related to alterations in nanoscale mechanical integrity, a hypothesis that requires
additional study.
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Figure 1. Type I Collagen Fibrillar Organization
Collagen is initially synthesized as a polypeptide chain of amino acids with an uninterrupted
region of repeating Gly-X-Y triplets (X and Y are often proline and hydroxyproline,
respectively). The significance of glycine being present as every third amino acid is that its
small side chain (a single hydrogen atom) can be accommodated within the central axis of
the left-handed α helix. Three of these helical chains then form a right-handed triple helix.
Once secreted from the cell, non-helical propeptide ends are enzymatically cleaved leaving a
300 nm long, 1.5 nm wide tropocollagen molecule. Tropcollagen molecules self-assemble in
a staggered, parallel manner to form a 3D fibril. Because of the space between the ends of
the tropocollagen molecules and the offset from row to row, regions of gaps and overlaps
exist within the fibril and produce an oscillating surface topography with a characteristic
axial repeat pattern called the D-periodicity. In the Brtl/+ disease model, a cysteine residue
substitutes for a glycine at the 349 amino acid position in an α1 helix (about 1/3 of the
distance in from the left end of the helical portion of the molecules shown above, indicated
by the star).
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Figure 2. Schematic Representation of the Processed Mouse Femur
Panel a shows a 3D image of a mouse femur, with the anterior surface of the femur facing
the reader (proximal end left, distal end right). Along the length of the femur, 9 locations
were analyzed to investigate the collagen fibril ultrastructure (panel b). The femur was
polished to create a flat intracortical region to image (panel c).
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Figure 3. Schematic Representation of Two Dimensional Fast Fourier Transform Measurements
Panel a shows a representative 3.5 μm × 3.5 μm amplitude image that was used to measure
the collagen fibril D-periodicity. The box represents a fibril that was chosen for
measurement. Panel b shows the corresponding 2D FFT from this fibril. As indicated, the
2D power spectrum contains information about the harmonic characteristics of the fibril.
The circled peaks are the first harmonic of the spectrum. The maximum value in this peak
corresponds to the D-Periodic repeat distance of the fibril.
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Figure 4. D-Periodic Spacings from Murine Femora as a Function of Axial Location
This figure shows the boxplot representation of the D-periodic spacing from WT (A) and
Brtl/+ (B) bones as a function of axial location. The dashed horizontal line indicates the
expected 67 nm repeat distance. For each sample, the box is the interquartile region (middle
50% of the data), the horizontal line inside of the box is the median, and the diamond is the
mean. The whiskers on the box are the minimum and maximum observation for that
location. Qualitatively, there is greater variability between axial locations in the Brtl/+ bones
(B) in comparison to the WT (A) bones.
Wallace et al. Page 13













Figure 5. D-Periodic Spacings from Murine Femora
Boxplot representation of the D-periodic spacing from the 4 bones in each genotype. The
dashed horizontal line indicates the theoretical 67 nm repeat distance. When the mean values
from the 4 samples in each group were compared by One Way ANOVA, WT and Brtl/+
mice (p=0.392) did not differ significantly.
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Figure 6. Histogram and Cumulative Density Function of D-Periodic Spacings from Murine
Bone
Panel A shows the histogram representation of the D-Periodic spacing from WT and Brtl/+
bones (1 nm bin size). Panel B displays the Cumulative Density Function (CDF) calculated
from each group. The CDF shows the fraction of a given sample that is contained up to a
particular value. A Kolmogorov-Smirnov test performed on the data distributions indicates
that there is a significant differences in the population distributions between WT and Brtl/
+mice (p=0.001).
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